CN112513292A - 基于高通量测序检测同源序列的方法和装置 - Google Patents
基于高通量测序检测同源序列的方法和装置 Download PDFInfo
- Publication number
- CN112513292A CN112513292A CN201880096241.7A CN201880096241A CN112513292A CN 112513292 A CN112513292 A CN 112513292A CN 201880096241 A CN201880096241 A CN 201880096241A CN 112513292 A CN112513292 A CN 112513292A
- Authority
- CN
- China
- Prior art keywords
- sequence
- homologous
- throughput sequencing
- reads
- homologous sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012165 high-throughput sequencing Methods 0.000 title claims abstract description 67
- 238000000034 method Methods 0.000 title claims abstract description 51
- 230000003321 amplification Effects 0.000 claims abstract description 46
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 46
- 230000035772 mutation Effects 0.000 claims abstract description 18
- 238000012163 sequencing technique Methods 0.000 claims description 67
- 108090000623 proteins and genes Proteins 0.000 claims description 37
- 101000666610 Homo sapiens Blood group Rh(CE) polypeptide Proteins 0.000 claims description 23
- 108010001237 Cytochrome P-450 CYP2D6 Proteins 0.000 claims description 19
- 102100021704 Cytochrome P450 2D6 Human genes 0.000 claims description 19
- 101000896576 Homo sapiens Putative cytochrome P450 2D7 Proteins 0.000 claims description 17
- 235000019506 cigar Nutrition 0.000 claims description 11
- 210000000349 chromosome Anatomy 0.000 claims description 8
- 230000008685 targeting Effects 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 102100027544 Blood group Rh(D) polypeptide Human genes 0.000 description 68
- 239000000523 sample Substances 0.000 description 24
- 101150108975 Rhd gene Proteins 0.000 description 23
- 102100038341 Blood group Rh(CE) polypeptide Human genes 0.000 description 19
- 206010011878 Deafness Diseases 0.000 description 18
- 239000003814 drug Substances 0.000 description 18
- 229940079593 drug Drugs 0.000 description 18
- 238000001514 detection method Methods 0.000 description 14
- 208000016354 hearing loss disease Diseases 0.000 description 14
- 101150032892 RHCE gene Proteins 0.000 description 13
- 231100000895 deafness Toxicity 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 12
- 108700024394 Exon Proteins 0.000 description 11
- 102100021702 Putative cytochrome P450 2D7 Human genes 0.000 description 11
- 101150010738 CYP2D6 gene Proteins 0.000 description 10
- 238000012408 PCR amplification Methods 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 238000012217 deletion Methods 0.000 description 7
- 230000037430 deletion Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 238000007403 mPCR Methods 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000012937 correction Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000026350 Inborn Genetic disease Diseases 0.000 description 3
- 238000004590 computer program Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 208000016361 genetic disease Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000969 carrier Substances 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 101150072890 CYP2D7 gene Proteins 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 101000896586 Homo sapiens Cytochrome P450 2D6 Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000036267 drug metabolism Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003617 erythrocyte membrane Anatomy 0.000 description 1
- 208000001031 fetal erythroblastosis Diseases 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 102200026593 rs1065852 Human genes 0.000 description 1
- 102220005866 rs35742686 Human genes 0.000 description 1
- 102220005865 rs5030865 Human genes 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
一种基于高通量测序检测同源序列的方法和装置,所述方法包括:获取样本的一对同源序列的特异性扩增产物的高通量测序结果,特异性扩增产物包含至少一个用于区分同源序列的序列特异性位点;将高通量测序结果与参考序列进行比对,并根据序列特异性位点将高通量测序结果区分为两组,每组归属于一个同源序列;将每组归属于一个同源序列的高通量测序结果分别与去除了另一个同源序列的参考序列进行比对;和统计比对到去除了另一个同源序列的参考序列的reads数目,根据reads数确定样本的同源序列信息。本发明能够解决同源序列来源的精确定位问题,实现准确检测突变的目的。
Description
PCT国内申请,说明书已公开。
Claims (15)
- PCT国内申请,权利要求书已公开。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2018/102546 WO2020041946A1 (zh) | 2018-08-27 | 2018-08-27 | 基于高通量测序检测同源序列的方法和装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112513292A true CN112513292A (zh) | 2021-03-16 |
CN112513292B CN112513292B (zh) | 2023-12-26 |
Family
ID=69642718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880096241.7A Active CN112513292B (zh) | 2018-08-27 | 2018-08-27 | 基于高通量测序检测同源序列的方法和装置 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112513292B (zh) |
WO (1) | WO2020041946A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114457169A (zh) * | 2022-03-07 | 2022-05-10 | 南京鼓楼医院 | 一种基于高通量测序的RhD基因型检测方法 |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003056030A2 (en) * | 2001-11-08 | 2003-07-10 | The Johns Hopkins University | Methods and systems of nucleic acid sequencing |
CN104531883A (zh) * | 2015-01-14 | 2015-04-22 | 北京圣谷同创科技发展有限公司 | Pkd1基因突变的检测试剂盒及检测方法 |
WO2016023962A1 (en) * | 2014-08-13 | 2016-02-18 | Progenika Biopharma S.A. | Consensus-based allele detection |
CN105567830A (zh) * | 2016-01-29 | 2016-05-11 | 江汉大学 | 一种植物转基因成分的检测方法 |
CN106282356A (zh) * | 2016-08-30 | 2017-01-04 | 天津诺禾医学检验所有限公司 | 一种基于扩增子二代测序点突变检测的方法及装置 |
CN106367475A (zh) * | 2015-07-23 | 2017-02-01 | 上海生物信息技术研究中心 | 一种mmr基因突变检测试剂盒 |
CN106372459A (zh) * | 2016-08-30 | 2017-02-01 | 天津诺禾致源生物信息科技有限公司 | 一种基于扩增子二代测序拷贝数变异检测的方法及装置 |
WO2017156290A1 (en) * | 2016-03-09 | 2017-09-14 | Baylor College Of Medicine | A novel algorithm for smn1 and smn2 copy number analysis using coverage depth data from next generation sequencing |
CN107653299A (zh) * | 2016-07-23 | 2018-02-02 | 成都十洲科技有限公司 | 一种基于高通量测序的基因芯片探针序列的获取方法 |
CN107688727A (zh) * | 2016-08-05 | 2018-02-13 | 深圳华大基因股份有限公司 | 生物序列聚类和全长转录组中转录本亚型识别方法和装置 |
CN108103204A (zh) * | 2017-12-15 | 2018-06-01 | 东莞博奥木华基因科技有限公司 | 基于多重PCR及二代测序的Rh血型分型方法及装置 |
WO2018112249A1 (en) * | 2016-12-15 | 2018-06-21 | Illumina, Inc. | Methods and systems for determining paralogs |
CN108424907A (zh) * | 2018-05-09 | 2018-08-21 | 北京大学 | 一种高通量dna多位点精确碱基突变方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102965367B (zh) * | 2012-12-04 | 2014-06-18 | 中国农业科学院棉花研究所 | 一种获得棉花候选抗黄萎病基因序列的方法 |
CN105112569B (zh) * | 2015-09-14 | 2017-11-21 | 中国医学科学院病原生物学研究所 | 基于宏基因组学的病毒感染检测及鉴定方法 |
-
2018
- 2018-08-27 WO PCT/CN2018/102546 patent/WO2020041946A1/zh active Application Filing
- 2018-08-27 CN CN201880096241.7A patent/CN112513292B/zh active Active
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003056030A2 (en) * | 2001-11-08 | 2003-07-10 | The Johns Hopkins University | Methods and systems of nucleic acid sequencing |
WO2016023962A1 (en) * | 2014-08-13 | 2016-02-18 | Progenika Biopharma S.A. | Consensus-based allele detection |
CN104531883A (zh) * | 2015-01-14 | 2015-04-22 | 北京圣谷同创科技发展有限公司 | Pkd1基因突变的检测试剂盒及检测方法 |
CN106367475A (zh) * | 2015-07-23 | 2017-02-01 | 上海生物信息技术研究中心 | 一种mmr基因突变检测试剂盒 |
CN105567830A (zh) * | 2016-01-29 | 2016-05-11 | 江汉大学 | 一种植物转基因成分的检测方法 |
WO2017156290A1 (en) * | 2016-03-09 | 2017-09-14 | Baylor College Of Medicine | A novel algorithm for smn1 and smn2 copy number analysis using coverage depth data from next generation sequencing |
CN107653299A (zh) * | 2016-07-23 | 2018-02-02 | 成都十洲科技有限公司 | 一种基于高通量测序的基因芯片探针序列的获取方法 |
CN107688727A (zh) * | 2016-08-05 | 2018-02-13 | 深圳华大基因股份有限公司 | 生物序列聚类和全长转录组中转录本亚型识别方法和装置 |
CN106372459A (zh) * | 2016-08-30 | 2017-02-01 | 天津诺禾致源生物信息科技有限公司 | 一种基于扩增子二代测序拷贝数变异检测的方法及装置 |
CN106282356A (zh) * | 2016-08-30 | 2017-01-04 | 天津诺禾医学检验所有限公司 | 一种基于扩增子二代测序点突变检测的方法及装置 |
WO2018112249A1 (en) * | 2016-12-15 | 2018-06-21 | Illumina, Inc. | Methods and systems for determining paralogs |
CN108103204A (zh) * | 2017-12-15 | 2018-06-01 | 东莞博奥木华基因科技有限公司 | 基于多重PCR及二代测序的Rh血型分型方法及装置 |
CN108424907A (zh) * | 2018-05-09 | 2018-08-21 | 北京大学 | 一种高通量dna多位点精确碱基突变方法 |
Non-Patent Citations (2)
Title |
---|
CHEN F等: "High-Throughput Sequencing Reveals Single Nucleotide Variants in Longer-Kernel Bread Wheat", 《FRONT PLANT SCI》, vol. 7, pages 1 - 10 * |
SIMON MM等: "High throughput sequencing approaches to mutation discovery in the mouse", 《MAMM GENOME》, vol. 23, no. 9, pages 499 - 513, XP035120571, DOI: 10.1007/s00335-012-9424-0 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114457169A (zh) * | 2022-03-07 | 2022-05-10 | 南京鼓楼医院 | 一种基于高通量测序的RhD基因型检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN112513292B (zh) | 2023-12-26 |
WO2020041946A1 (zh) | 2020-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Guo et al. | Three-stage quality control strategies for DNA re-sequencing data | |
Sheng et al. | Multi-perspective quality control of Illumina RNA sequencing data analysis | |
Krawitz et al. | Microindel detection in short-read sequence data | |
EP4112740B1 (en) | Size-based analysis of fetal dna fraction in maternal plasma | |
CN105441432B (zh) | 组合物及其在序列测定和变异检测中的用途 | |
CN109767810B (zh) | 高通量测序数据分析方法及装置 | |
CN111341383B (zh) | 一种检测拷贝数变异的方法、装置和存储介质 | |
CN107077537A (zh) | 用短读测序数据检测重复扩增 | |
AU2016355983B2 (en) | Methods for detecting copy-number variations in next-generation sequencing | |
CN113249453B (zh) | 一种检测拷贝数变化的方法 | |
US20170101670A1 (en) | Method for detecting rare mutation | |
CN109461473B (zh) | 胎儿游离dna浓度获取方法和装置 | |
CN113564266B (zh) | Snp分型遗传标记组合、检测试剂盒及用途 | |
WO2022029688A1 (en) | Highly sensitive method for detecting cancer dna in a sample | |
Kubiritova et al. | On the critical evaluation and confirmation of germline sequence variants identified using massively parallel sequencing | |
CN112513292B (zh) | 基于高通量测序检测同源序列的方法和装置 | |
Benaglio et al. | Ultra high throughput sequencing in human DNA variation detection: a comparative study on the NDUFA3-PRPF31 region | |
CN112639129A (zh) | 确定新发突变在胚胎中的遗传状态的方法和装置 | |
CA3189557A1 (en) | Highly sensitive method for detecting cancer dna in a sample | |
US20200075124A1 (en) | Methods and systems for detecting allelic imbalance in cell-free nucleic acid samples | |
US20230332220A1 (en) | Random insertion genome reconstruction | |
Vermeulen | Improving and estimating Y chromosome loss in blood and brain tissues using high-throughput sequencing | |
Willcox et al. | RNA Strain-Match: A tool for matching single-nucleus, single-cell, or bulk RNA-sequencing alignment data to its corresponding genotype | |
CN116705153A (zh) | 确定snp检测区域的方法和对测序样本进行校正的方法 | |
CN113528648A (zh) | 基于基因突变和dna甲基化特征判定衰老程度的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |